Flax Health

About Flax Health

Flax Health focuses on AI and automation for skilled nursing facilities, aiming to turn time-consuming paperwork into profit by automating processes from referral to appeal, thereby increasing profitability, reducing staff burnout, and cutting appeal times.

Products & Services

Admissions:Summarizes referrals, assesses them against criteria, and helps respond to the best referrals faster while flagging unfit patients. Responds to referrals in 2 minutes by pulling data from portals.

Intake:Populates MDS forms using patient referral data, saving nurses time by extracting PDPM-driving information and ensuring accurate, compliant documentation.

Claims:Auto-generates claims and appeals using evidence from clinical notes, reducing denials, write-offs, and delayed payments while capturing the full complexity of care.

Specialties

AI for Skilled Nursing Automation of Paperwork Clinical Documentation Compliance and Reimbursement Optimization

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Pre-Seed T: - FT: Pre-Seed	A: 3500000 MR: - FA: 3.5 million FAN: 3500000	D: 2025-09-04 FD: 2025-09-04	2 investors

Pre-Seed Latest

2025-09-04

$3.5M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Trent Hazy

Co-Founder

D

David Kartchner

Co-Founder

Recent News

Flax Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised